Activist Bluebell Capital Takes Small Stake in GSK to Push for Board Change -FT
September 23 2021 - 6:31AM
Dow Jones News
--Activist hedge fund Bluebell Capital Partners has taken a
small stake in GlaxoSmithKline PLC to push for Chief Executive Emma
Walmsley to reapply for her job, the Financial Times reports.
--Bluebell said the pharma company should launch a "thorough and
robust process" to find a leader as Ms. Walmsley's time as CEO has
resulted in lower shareholder returns than those of rivals,
according to the FT.
Full story: https://on.ft.com/3kwC1sP
Write to Anthony O. Goriainoff at
anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
September 23, 2021 06:16 ET (10:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024